Home›Stock Screener›Wockhardt›Financial Statements

Wockhardt Financial Statements

12 Years of Data
2026 - 2015

Wockhardt financial statements. In FY2026, Wockhardt (WOCKPHARMA) reported revenue ₹980 Cr, net profit ₹73 Cr and EPS ₹4.85, with a net profit margin of 7.4% and ROE of 1.4%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore WOCKPHARMA fundamental worth to estimate fundamental worth using multiple valuation models.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 7.45% 2026 data
EBITDA Margin 18.78% 2026 data
Operating Margin 18.00% 2026 data
Return on Assets 0.85% 2026 data
Return on Equity 1.38% 2026 data

Balance Sheet Ratios

Equity Ratio 61.30% 2026 data
Asset Turnover 0.11 2026 data

WOCKPHARMA Revenue, Net Profit & EBITDA — Year-on-Year Growth

WOCKPHARMA YoY (Sept 2025 vs Sept 2026) — revenue +22.0%, net profit -11.0%, EBITDA -7.5%, expenses +31.8%. For live price, earnings ratios and company overview, see WOCKPHARMA share price screener.

Revenue Growth
+22.0%
Year-over-Year
Net Profit Growth
-11.0%
Year-over-Year
EBITDA Growth
-7.5%
Year-over-Year
Expense Growth
+31.8%
Year-over-Year
Assets Growth
+5.9%
Year-over-Year
Equity Growth
+13.4%
Year-over-Year
Operating Cash Flow Growth
+1872.7%
Year-over-Year
Investing Cash Flow Growth
+70.4%
Year-over-Year
Financing Cash Flow Growth
-113.2%
Year-over-Year

WOCKPHARMA Income Statement — Revenue, EBITDA & Net Profit

Wockhardt revenue ₹980 Cr, EBITDA ₹184 Cr, net profit ₹73 Cr, EPS ₹4.85 (2026) — net profit margin 7.4%. See WOCKPHARMA price book multiple to compare market price against book value per share.

Periods ₹ Crores
Particulars Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Mar 2021 Jun 2021 Dec 2021 Sept 2020 Mar 2020 Jun 2020 Dec 2020 Sept 2019 Mar 2019 Jun 2019 Dec 2019 Sept 2018 Mar 2018 Jun 2018 Dec 2018 Sept 2017 Mar 2017 Jun 2017 Dec 2017 Sept 2016 Mar 2016 Jun 2016 Dec 2016 Sept 2015 Mar 2015 Jun 2015 Dec 2015
Revenue 980 1,032 960 803 758 758 913 818 754 769 729 777 710 658 709 736 669 652 701 866 640 861 856 730 720 2,077 865 705 880 760 807 1,132 1,010 1,015 1,048 1,077 920 928 1,042 1,083 1,028 1,108 1,018 1,206 1,052 1,160 1,116
Expenses 796 740 737 604 679 763 721 699 803 648 593 681 771 642 664 831 871 611 657 765 698 739 742 697 674 1,298 706 670 827 726 656 1,058 1,024 1,003 1,064 1,001 1,028 1,309 959 964 945 1,016 995 1,031 943 973 1,001
EBITDA 184 292 223 199 79 -5 192 119 -49 121 136 96 -61 16 45 -95 -202 41 44 101 -58 122 114 33 47 779 159 35 53 34 151 74 -15 12 -16 76 -108 -381 84 119 83 92 23 175 109 187 116
Operating Profit Margin % 18.00% 23.00% 21.00% 23.00% 9.00% -3.00% 19.00% 14.00% -15.00% 12.00% 18.00% 10.00% -14.00% 0.00% 5.00% -22.00% -33.00% -3.00% 6.00% 11.00% -10.00% 14.00% 13.00% 2.00% 2.00% -117.00% 8.00% 2.00% 4.00% 0.00% 12.00% 6.00% -1.00% 0.00% -2.00% 2.00% -19.00% -47.00% 5.00% 9.00% 6.00% 7.00% 0.00% 16.00% 13.00% 15.00% 7.00%
Depreciation 55 53 55 53 53 56 65 55 58 54 55 55 56 55 55 65 59 64 66 61 65 64 62 57 61 56 68 53 45 55 56 40 38 39 41 36 37 37 38 37 37 36 38 35 34 35 36
Interest 56 50 52 55 48 48 60 73 73 73 60 76 76 79 77 70 86 73 83 69 55 64 80 61 61 74 60 65 64 71 79 65 65 73 64 68 59 61 62 56 43 49 61 30 14 24 32
Profit Before Tax 73 189 116 91 -22 -109 67 -9 -180 -6 21 -35 -193 -118 -87 -230 -347 -96 -105 -29 -178 -6 -28 -85 -75 649 31 -82 -55 -92 16 -32 -118 -100 -121 -28 -204 -480 -16 26 4 7 -76 110 60 128 48
Tax 0 25 9 9 23 -1 6 7 -3 10 1 38 44 18 -1 -23 -36 -21 -3 -66 -71 1 -30 -88 -144 -111 -1 12 -41 -55 -3 -1 35 -5 -44 -19 3 -17 27 1 17 -9 -16 12 27 30 -22
Net Profit 73 164 107 82 -45 -108 61 -16 -177 -16 20 -73 -237 -136 -86 -207 -311 -75 -102 37 -107 -7 2 3 69 760 32 -94 -14 -37 19 -31 -153 -95 -77 -9 -207 -463 -43 25 -13 17 -60 98 33 98 69
Earnings Per Share (₹) 4.85 10.23 6.55 4.81 -1.57 -5.53 3.61 -1.47 -11.64 -0.95 0.91 -5.37 -14.37 -9.28 -5.75 -13.15 -21.20 -4.64 -6.62 2.79 -8.38 -1.15 -0.61 0.32 4.36 68.64 1.38 -7.42 -2.62 -4.06 0.87 -2.06 -13.97 -7.79 -6.42 -0.80 -15.81 -37.06 -3.69 2.25 -0.49 1.44 -4.88 8.37 3.10 8.36 6.52

WOCKPHARMA Balance Sheet — Assets, Liabilities & Shareholders' Equity

WOCKPHARMA total assets ₹8,615 Cr, total equity ₹5,281 Cr, total liabilities ₹ Cr (2026) — ROE 1.4%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 8,615 8,135 7,649 7,683 8,243 7,774 8,179 7,844 8,162 9,022 8,121 6,939
Current Assets
Fixed Assets 2,791 2,736 2,881 3,042 3,462 3,343 3,502 3,058 2,888 2,773 2,809 2,123
Capital Work in Progress 2,379 2,033 1,722 1,539 1,342 1,379 1,585 1,446 1,433 1,244 1,036 1,007
Investments 412 422 0 0 0 0 0 0 214 563 0 339
Other Assets 3,033 2,944 3,046 3,102 3,439 3,052 3,092 3,341 3,628 4,443 4,276 3,470
LIABILITIES
Total Liabilities
Current Liabilities 1,712 1,436 1,196 586 834 894 1,624 1,976 2,272 3,324 2,039 1,307
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 5,281 4,657 3,662 3,662 4,202 3,759 3,058 3,005 3,198 3,719 4,241 3,859
Share Capital 81 81 77 72 72 55 55 55 55 55 55 354
Reserves & Surplus 4,859 4,272 3,282 3,282 3,777 3,321 2,616 2,620 2,797 3,281 3,720 3,362

WOCKPHARMA Cash Flow Statement — Operating, Investing & Financing

Wockhardt operating cash flow ₹390 Cr, investing ₹-231 Cr, financing ₹-54 Cr, net cash flow ₹105 Cr (2026).

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 390 -22 219 153 413 -287 649 183 68 -270 -42 355
Investing Activities -231 -780 -138 -118 -204 1,471 -147 93 635 -684 -106 -222
Financing Activities -54 409 334 -315 -71 -1,171 -680 -777 -770 1,255 193 -76
Net Cash Flow 105 -393 415 -280 138 13 -178 -500 -66 301 46 57